What is the price-to-earnings ratio of Seagen?
The price-earnings ratio of Seagen is currently -111.36.
Seagen P/E 2024
Seagen P/E
-111.36
Ticker
SGEN
ISIN
US81181C1045
WKN
602322
As of Sep 13, 2024, Seagen's P/E ratio was -111.36, a 148.24% change from the -44.86 P/E ratio recorded in the previous year.
The Seagen P/E history
Seagen Aktienanalyse
What does Seagen do?
Seagen Inc is a pharmaceutical and biotech company specialized in the development of drugs for cancer treatment and supporting the health of patients with chronic diseases. The company was founded in 1997 and has its headquarters in Bothell, Washington. Seagen Inc's history began when the founders, Clay Siegall and H. Perry Fell, decided to establish a company focused on developing innovative technologies and biological solutions for fighting cancer. The company started with a small workforce and a focus on the development of antibodies against cancer cells. Over the years, Seagen has become a major player in the industry and has launched several successful drugs worldwide. Seagen Inc specializes in the development of cancer medications, including antibodies against cancer cells. The company strives to improve the effectiveness of cancer treatments and reduce the number of side effects. Its flagship products are Adcetris and Padcev, both used for the treatment of specific types of cancer. Adcetris (Brentuximab Vedotin) is an antibody-drug conjugate and the first of its kind approved worldwide for use against Hodgkin lymphomas and systemic anaplastic large cell lymphoma. It contains a special chemical that is bound to an antibody to directly attack cancer cells. Adcetris has proven to be very effective against lymphomas and is available on prescription in many countries. Padcev (Enfortumab Vedotin-ejfv) is another antibody-drug conjugate used for the treatment of bladder cancer. The drug has shown effectiveness in clinical studies and has been approved by the FDA to help patients who have no other treatment options. Padcev is being developed and marketed by Seagen in collaboration with Astellas Pharma. In addition to developing cancer medications, Seagen Inc is also involved in the research and development of technologies for autoimmune disease therapy. The company has developed a technology platform that has proven to be highly effective in the development of antibody-based therapies. This platform is used both internally and in partnerships with other pharmaceutical companies. Seagen Inc also leverages partnerships to expand its business globally and advance the development of new therapies. The company has entered into a strategic partnership with Takeda Pharmaceutical to support the development and commercialization of Adcetris. Additionally, Seagen Inc collaborates with various universities and research institutions to develop new technologies and treatment options. Overall, Seagen Inc has experienced strong growth in recent years and has become a major player in the biotech and pharmaceutical industry. The company remains committed to its mission of developing innovative technologies and solutions for fighting cancer and other chronic diseases. Seagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Seagen's P/E Ratio
The Price to Earnings (P/E) Ratio of Seagen is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Seagen's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Seagen is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Seagen’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Seagen stock
How has the price-earnings ratio of Seagen changed compared to last year?
The price-to-earnings ratio of Seagen has increased by 148.24% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Seagen high compared to other companies?
Yes, the price-to-earnings ratio of Seagen is high compared to other companies.
How does an increase in the price-earnings ratio of Seagen affect the company?
An increase in the price-earnings ratio of Seagen would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Seagen affect the company?
A decrease in the price-earnings ratio of Seagen would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Seagen?
Some factors that influence the price-earnings ratio of Seagen are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Seagen pay?
Over the past 12 months, Seagen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Seagen is expected to pay a dividend of 0 USD.
What is the dividend yield of Seagen?
The current dividend yield of Seagen is .
When does Seagen pay dividends?
Seagen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Seagen?
Seagen paid dividends every year for the past 0 years.
What is the dividend of Seagen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Seagen located?
Seagen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Seagen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Seagen from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.
When did Seagen pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Seagen in the year 2023?
In the year 2023, Seagen distributed 0 USD as dividends.
In which currency does Seagen pay out the dividend?
The dividends of Seagen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Seagen
Our stock analysis for Seagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Seagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
